NCT06873737View on ClinicalTrials.gov

Analysis of the Levels of HLADR+ Extracellular Vesicles in Women With Preeclampsia as a Early Potential Biomarker

NAActive, not recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

September 30, 2023

Study Completion Date

January 1, 2026

Conditions
Preeclampsia
Interventions
OTHER

Blood samples for inflammatory markers

Blood sampling in the first, second, trimester of pregnancy

Trial Locations (1)

00168

Fondazione Policlinico Universitario Agostino Gemelli, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER